Clarivate (NYSE:CLVT) Shares Up 6.7% – Time to Buy?

Clarivate PLC (NYSE:CLVT) shot up 6.7% during mid-day trading on Monday . The stock traded as high as $2.92 and last traded at $2.9760. 224,744 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 6,817,749 shares. The stock had previously closed at $2.79.

Wall Street Analyst Weigh In

Several brokerages have issued reports on CLVT. Wall Street Zen raised shares of Clarivate from a “hold” rating to a “buy” rating in a report on Saturday. The Goldman Sachs Group downgraded shares of Clarivate from a “buy” rating to a “neutral” rating and reduced their price target for the company from $4.20 to $3.60 in a report on Thursday, January 8th. Barclays reduced their price target on shares of Clarivate from $4.00 to $2.40 and set an “underweight” rating on the stock in a report on Wednesday, February 25th. Royal Bank Of Canada reduced their price target on shares of Clarivate from $5.00 to $3.00 and set a “sector perform” rating on the stock in a report on Wednesday, February 25th. Finally, Citigroup reduced their price target on shares of Clarivate from $4.25 to $2.80 and set a “neutral” rating on the stock in a report on Wednesday, March 4th. Five investment analysts have rated the stock with a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus price target of $3.22.

Clarivate Stock Up 0.9%

The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 0.89. The firm has a market cap of $1.79 billion, a PE ratio of -13.31 and a beta of 1.41. The firm’s 50 day moving average is $2.52 and its 200-day moving average is $2.93.

Clarivate (NYSE:CLVT) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.04. The business had revenue of $585.50 million for the quarter, compared to the consensus estimate of $569.50 million. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The company’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.14 earnings per share. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. As a group, equities research analysts expect that Clarivate PLC will post 0.65 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Clarivate

Institutional investors and hedge funds have recently modified their holdings of the company. M&T Bank Corp purchased a new position in shares of Clarivate during the fourth quarter valued at approximately $34,000. Essex Financial Services Inc. purchased a new position in shares of Clarivate during the third quarter valued at approximately $41,000. PharVision Advisers LLC purchased a new position in shares of Clarivate during the third quarter valued at approximately $45,000. Personal CFO Solutions LLC purchased a new position in shares of Clarivate during the first quarter valued at approximately $30,000. Finally, Pitcairn Co. acquired a new position in Clarivate during the second quarter worth approximately $52,000. Hedge funds and other institutional investors own 85.72% of the company’s stock.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.